Bio Medica Laboratories (NSE:BMLL) ROCE %: 82.45% (As of Mar. 2025)


NSE:BMLL Bio Medica Laboratories Ltd NSE:BMLL
14 GF Score
Price ₹144.10
! 2 Warning Signs
View Full Analysis

What is Bio Medica Laboratories ROCE %?

Bio Medica Laboratories NSE:BMLL +0.49% 14 ROCE % is 82.45% as of Mar. 2025. GuruFocus rates NSE:BMLL with a GF Score™ of 14/100. The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Bio Medica Laboratories's annualized ROCE % for the quarter that ended in Mar. 2025 was 82.45%.

Bio Medica Laboratories  (NSE:BMLL) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Bio Medica Laboratories ROCE % Related Terms

Bio Medica Laboratories ROCE % Historical Data

* Premium members only.

The historical data trend for Bio Medica Laboratories's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio Medica Laboratories ROCE % Chart

Bio Medica Laboratories Annual Data
Trend Mar23 Mar24 Mar25
ROCE %
15.99 45.09 82.45

Bio Medica Laboratories Semi-Annual Data
Mar23 Mar24 Mar25
ROCE % 15.99 45.09 82.45
NSE:BMLL
14GF Score
Bio Medica Laboratories Ltd NSE:BMLL
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bio Medica Laboratories ROCE % Calculation

Bio Medica Laboratories's annualized ROCE % for the fiscal year that ended in Mar. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2025 )  (A: Mar. 2024 )(A: Mar. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2025 )  (A: Mar. 2024 )(A: Mar. 2025 )
=144.702/( ( (195.308 - 65.559) + (391.179 - 169.943) )/ 2 )
=144.702/( (129.749+221.236)/ 2 )
=144.702/175.4925
=82.45 %

Bio Medica Laboratories's ROCE % of for the quarter that ended in Mar. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2025 )  (Q: Mar. 2024 )(Q: Mar. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2025 )  (Q: Mar. 2024 )(Q: Mar. 2025 )
=144.702/( ( (195.308 - 65.559) + (391.179 - 169.943) )/ 2 )
=144.702/( ( 129.749 + 221.236 )/ 2 )
=144.702/175.4925
=82.45 %

(1) Note: The EBIT data used here is one times the annual (Mar. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 82.45% mean?
Bio Medica Laboratories (NSE:BMLL) has a ROCE % of 82.45% as of Mar. 2025.
Is Bio Medica Laboratories' ROCE % too high?
Bio Medica Laboratories' current ROCE % is 82.45%. The Medical Devices & Instruments industry median ROCE % is 2.20. Bio Medica Laboratories' value of 82.45% is 3647.7% above this industry median. Overall, Bio Medica Laboratories has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Bio Medica Laboratories' ROCE % compare to ISRG and BDX?
Bio Medica Laboratories' ROCE % of 82.45% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.20. Bio Medica Laboratories' value of 82.45% is 3647.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.20, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bio Medica Laboratories's current ROCE % of 82.45% is 3647.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bio Medica Laboratories's current ROCE % is 82.45%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio Medica Laboratories stock overvalued right now?
Bio Medica Laboratories (NSE:BMLL) has a current ROCE % of 82.45%. The current ROCE % is 82.45% and 3647.7% above the Medical Devices & Instruments industry median of 2.20. Bio Medica Laboratories' overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Bio Medica Laboratories (NSE:BMLL), the current ROCE % is 82.45% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bio Medica Laboratories Business Description

Address Sanwer Road, Plot No. 11B-11C, Sector-E, Industrial Area, Industrial Estate - Indore, Indore, MP, IND, 452015
Bio Medica Laboratories Ltd is engaged in the manufacturing of Pharmaceutical Parenteral Formulations. It manufactures generic drugs in the form of injectables namely Liquid Injections and Dry Powder Injections. These injectables are available in both single dose and multi dose forms, catering both human and veterinary needs. Its products address a wide range of medical needs and preferences. The majority of revenue is derived from the sales of Liquid injections. Geographically, it operates predominantly in India, and internationally, it exports to Afghanistan.
14GF Score

Get the complete analysis for NSE:BMLL

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹144.10
Price